Onsdag 28 Oktober | 18:10:51 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Integrum - A neutral performance in Q3

2022-03-07 10:00:00

Redeye returns with a more in-depth take of the Q3’21 report, which reflected a relatively neutral financial development. We have downed our sales estimates for the coming years due to a continuous uncertainty in elective surgery capacities and reconsiderations of contribution from the VA program in the shorter term – this poses a slight reassessment to our fair value range.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/